Meet the user where their new problem is
While semaglutide has shown impressive results, one major hurdle for many people is the cost
Just expert-led care that fits your standards
Its estimated that the use of this class of drugs, which are also used to treat type 2 diabetes, could reach 125 billion USD in Europe and the US by 2033, according to a report by data analytics firm, GlobalData
Studies show that PUFA-phospholipids (PUFA-PLs) are phospholipids that are most likely to undergo peroxidation reactions (Gaschler and Stockwell, 2017), especially phosphatidylethanolamine (PE)-containing phospholipids with arachidonic acid (AA) and adrenic acid (AdA)
This will likely be an additional benefit for Novo if/when the 25mg dose receives medical approval for the treatment of T2D